Glioblastoma Multiforme Treatment Market Size, Share & Trends Report

Glioblastoma Multiforme Treatment Market Size, Share & Trends Analysis Report By Treatment (Radiation Therapy, Immunotherapy), By Drug Class, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68039-527-3
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Market Segmentation

  • Glioblastoma Multiforme Treatment Outlook (Revenue, USD Million, 2018 - 2030)
    • Surgery
    • Radiation therapy
    • Chemotherapy
    • Targeted Therapy
    • Tumor Treating Field (TTF) Therapy
    • Immunotherapy
  • Glioblastoma Multiforme Treatment Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
    • Temozolomide
    • Bevacizumab
    • Lomustine
    • Carmustine Wafers
    • Others
  • Glioblastoma Multiforme Treatment End-use Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
  • Glioblastoma Multiforme Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Glioblastoma Multiforme Treatment Market, Treatment Outlook
        • Surgery
        • Radiation therapy
        • Chemotherapy
        • Targeted Therapy
        • Tumor Treating Field (TTF) Therapy
        • Immunotherapy
      • North America Glioblastoma Multiforme Treatment Market, Drug Class Outlook
        • Temozolomide
        • Bevacizumab
        • Lomustine
        • Carmustine Wafers
        • Others
      • North America Glioblastoma Multiforme Treatment Market, End-use Outlook
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • U.S.
        • U.S. Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • U.S. Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • U.S. Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Canada
        • Canada Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Canada Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Canada Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
    • Europe
      • Europe Glioblastoma Multiforme Treatment Market, Treatment Outlook
        • Surgery
        • Radiation therapy
        • Chemotherapy
        • Targeted Therapy
        • Tumor Treating Field (TTF) Therapy
        • Immunotherapy
      • Europe Glioblastoma Multiforme Treatment Market, Drug Class Outlook
        • Temozolomide
        • Bevacizumab
        • Lomustine
        • Carmustine Wafers
        • Others
      • Europe Glioblastoma Multiforme Treatment Market, End-use Outlook
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • UK
        • UK Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • UK Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • UK Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Germany
        • Germany Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Germany Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Germany Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • France
        • France Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • France Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • France Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Italy
        • Italy Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Italy Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Italy Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Spain
        • Spain Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Spain Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Spain Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Sweden
        • Sweden Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Sweden Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Sweden Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Norway
        • Norway Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Norway Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Norway Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Denmark
        • Denmark Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Denmark Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Denmark Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
    • Asia Pacific
      • Asia Pacific Glioblastoma Multiforme Treatment Market, Treatment Outlook
        • Surgery
        • Radiation therapy
        • Chemotherapy
        • Targeted Therapy
        • Tumor Treating Field (TTF) Therapy
        • Immunotherapy
      • Asia Pacific Glioblastoma Multiforme Treatment Market, Drug Class Outlook
        • Temozolomide
        • Bevacizumab
        • Lomustine
        • Carmustine Wafers
        • Others
      • Asia Pacific Glioblastoma Multiforme Treatment Market, End-use Outlook
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • Japan
        • Japan Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Japan Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Japan Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • China
        • China Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • China Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • China Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • India
        • India Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • India Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • India Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Australia
        • Australia Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Australia Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Australia Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Thailand
        • Thailand Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Thailand Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Thailand Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • South Korea
        • South Korea Glioblastoma Multiforme Treatment Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • South Korea Glioblastoma Multiforme Treatment Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • South Korea Glioblastoma Multiforme Treatment Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
    • Latin America
      • Latin America Glioblastoma Multiforme Treatment Market, Treatment Outlook
        • Surgery
        • Radiation therapy
        • Chemotherapy
        • Targeted Therapy
        • Tumor Treating Field (TTF) Therapy
        • Immunotherapy
      • Latin America Glioblastoma Multiforme Treatment Market, Drug Class Outlook
        • Temozolomide
        • Bevacizumab
        • Lomustine
        • Carmustine Wafers
        • Others
      • Latin America Glioblastoma Multiforme Treatment Market, End-use Outlook
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • Brazil
        • Brazil Glioblastoma Multiforme Treatments Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Brazil Glioblastoma Multiforme Treatments Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Brazil Glioblastoma Multiforme Treatments Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Mexico
        • Mexico Glioblastoma Multiforme Treatments Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Mexico Glioblastoma Multiforme Treatments Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Mexico Glioblastoma Multiforme Treatments Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Argentina
        • Argentina Glioblastoma Multiforme Treatments Market, Treatment Outlook
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Argentina Glioblastoma Multiforme Treatments Market, Drug Class Outlook
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine Wafers
          • Others
        • Argentina Glioblastoma Multiforme Treatments Market, End-use Outlook
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
    • Middle East and Africa
      • Middle East and Africa Glioblastoma Multiforme Treatments Market, Treatment Outlook
        • Surgery
        • Radiation therapy
        • Chemotherapy
        • Targeted Therapy
        • Tumor Treating Field (TTF) Therapy
        • Immunotherapy
      • Middle East and Africa Glioblastoma Multiforme Treatments Market, Drug Class Outlook
        • Temozolomide
        • Bevacizumab
        • Lomustine
        • Carmustine Wafers
        • Others
      • Middle East and Africa Glioblastoma Multiforme Treatments Market, End-use Outlook
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • South Africa
          • South Africa Glioblastoma Multiforme Treatments Market, Treatment Outlook
            • Surgery
            • Radiation therapy
            • Chemotherapy
            • Targeted Therapy
            • Tumor Treating Field (TTF) Therapy
            • Immunotherapy
          • South Africa Glioblastoma Multiforme Treatments Market, Drug Class Outlook
            • Temozolomide
            • Bevacizumab
            • Lomustine
            • Carmustine Wafers
            • Others
          • South Africa Glioblastoma Multiforme Treatments Market, End-use Outlook
            • Hospitals
            • Clinics
            • Ambulatory Surgical Centers
        • Saudi Arabia
          • Saudi Arabia Glioblastoma Multiforme Treatments Market, Treatment Outlook
            • Surgery
            • Radiation therapy
            • Chemotherapy
            • Targeted Therapy
            • Tumor Treating Field (TTF) Therapy
            • Immunotherapy
          • Saudi Arabia Glioblastoma Multiforme Treatments Market, Drug Class Outlook
            • Temozolomide
            • Bevacizumab
            • Lomustine
            • Carmustine Wafers
            • Others
          • Saudi Arabia Glioblastoma Multiforme Treatments Market, End-use Outlook
            • Hospitals
            • Clinics
            • Ambulatory Surgical Centers
        • UAE
          • UAE Glioblastoma Multiforme Treatments Market, Treatment Outlook
            • Surgery
            • Radiation therapy
            • Chemotherapy
            • Targeted Therapy
            • Tumor Treating Field (TTF) Therapy
            • Immunotherapy
          • UAE Glioblastoma Multiforme Treatments Market, Drug Class Outlook
            • Temozolomide
            • Bevacizumab
            • Lomustine
            • Carmustine Wafers
            • Others
          • UAE Glioblastoma Multiforme Treatments Market, End-use Outlook
            • Hospitals
            • Clinics
            • Ambulatory Surgical Centers
        • Kuwait
          • Kuwait Glioblastoma Multiforme Treatments Market, Treatment Outlook
            • Surgery
            • Radiation therapy
            • Chemotherapy
            • Targeted Therapy
            • Tumor Treating Field (TTF) Therapy
            • Immunotherapy
          • Kuwait Glioblastoma Multiforme Treatments Market, Drug Class Outlook
            • Temozolomide
            • Bevacizumab
            • Lomustine
            • Carmustine Wafers
            • Others
          • Kuwait Glioblastoma Multiforme Treatments Market, End-use Outlook
            • Hospitals
            • Clinics
            • Ambulatory Surgical Centers

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon